MAPT and Alzheimer disease: Histologically, AD is largely defined by the accumulation of extracellular amyloid-β (Aβ)-containing plaques and intracellular abnormal tau neurofibrillary tangles (NFTs), both of which are recognized as key, though not the only, biomarkers and possible drivers of AD pathology (Knopman et al., 2021).